Identification of structural characteristics of some potential H2-receptor antagonists that determine the interaction with rat hepatic P-450.

[1]  H. Timmerman,et al.  Studies on histaminergic compounds vi. synthesis and structure activity relationships of a series of cimetidine and impromidine congeners , 1987 .

[2]  M. Murray,et al.  Mechanisms of the inhibition of cytochrome P-450-mediated drug oxidation by therapeutic agents. , 1987, Drug metabolism reviews.

[3]  U. Klotz,et al.  Comparative effects of H2-receptor antagonists on drug metabolism in vitro and in vivo. , 1987, Pharmacology & therapeutics.

[4]  D. Winzor,et al.  Evidence for induction of hepatic microsomal cytochrome P-450 by cimetidine: binding and kinetic studies. , 1986, Archives of biochemistry and biophysics.

[5]  R. Gugler,et al.  Cimetidine interaction with liver microsomes in vitro and in vivo. Involvement of an activated complex with cytochrome P-450. , 1985, Biochemical pharmacology.

[6]  C. F. Wilkinson,et al.  Interactions of nitrogen heterocycles with cytochrome P-450 and monooxygenase activity. , 1984, Chemico-biological interactions.

[7]  C. Walsh,et al.  An alternative 7-ethoxyresorufin O-deethylase activity assay: a continuous visible spectrophotometric method for measurement of cytochrome P-450 monooxygenase activity. , 1984, Analytical biochemistry.

[8]  A. Bast,et al.  Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  J. Noordhoek,et al.  Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat. , 1983, Research communications in chemical pathology and pharmacology.

[10]  D. Winzor,et al.  The interaction of cimetidine with rat liver microsomes. , 1983, Biochemical pharmacology.

[11]  H. Ruf,et al.  Characterization of cimetidine, ranitidine, and related structures' interaction with cytochrome P-450. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[12]  H. Ruf,et al.  Interaction of ranitidine with liver microsomes. , 1979, Xenobiotica; the fate of foreign compounds in biological systems.

[13]  J. Noordhoek,et al.  Calculation of competitive inhibition of substrate binding to cytochrome P-450 illustrated by the interaction of d,l-propranolol with d,l-hexobarbital. , 1980, Biochemical pharmacology.

[14]  C. Palomo,et al.  A Facile and Improved Synthesis of Cyanoguanidines from Carbodiimides , 1980 .

[15]  Rf Rekker,et al.  THE HYDROPHOBIC FRAGMENTAL CONSTANT; AN EXTENSION TO A 1000 DATA POINT SET , 1979 .

[16]  J. Bridges,et al.  The role of substrate lipophilicity in determining type 1 microsomal P450 binding characteristics. , 1978, Biochemical pharmacology.

[17]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[18]  C. F. Wilkinson,et al.  Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo. , 1974, Biochemical pharmacology.